Kelsey Loy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kelsey Loy has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Estela Sedeño Cortés
Division of Medical Genetics, University of Washington
2 shared publications - Andrew Stergachis
Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA, USA
2 shared publications - Chia-Lin Wei
University of Washington
2 shared publications - Dana M. Jensen
Seattle Children's Research Institute
2 shared publications - Evan E. Eichler
Department of Genome Sciences, University of Washington School of Medicine
2 shared publications - J Thomas Kolar
University of Washington
2 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Wiley in The Laryngoscope
Orbital Lymphatic Malformations Are Associated With Intracranial Vascular Anomalies
Objectives: Orbital lymphatic malformations (OLMs) are a rare type of lymphatic malformation involving the soft tissues within the bony orbit. OLMs present specific treatment challenges and cause significant morbidity. The contribution of pathologic genetic variants and potential association of intracranial vascular anomalies with OLMs has yet to be described. We hypothesized that (1) OLMs are indicators of underlying cerebrofacial venous metameric syndrome (CVMS) and are associated with intracranial vascular anomalies, and (2) OLMs are caused by PIK3CA variants and are candidates for targeted medical therapy. Methods: Retrospective case review was performed for patients with OLMs treated at a single institution from 2000 to 2025. Diagnosis of CVMS was made via magnetic resonance imaging (MRI) based on established criteria of segmental distribution of ocular, facial, and cerebral vascular malformations. Symptoms, MRI and genetic findings, and management are described. Results: Seven of 412 patients with head and neck lymphatic malformations had OLM. Common symptoms included eye swelling ( n = 7), ptosis ( n = 3), and headache ( n = 5). All patients were diagnosed with CVMS on MRI. All patients underwent surgical resection and were candidates for targeted medical therapy after tissue‐based DNA sequencing revealed “hotspot” PIK3CA variants p.E542K ( n = 4) and p.H1047R ( n = 3). Five patients were started on alpelisib, resulting in symptom improvement at 6 months of treatment. Conclusion: OLMs were associated with intracranial vascular anomalies, meeting radiographic criteria for CVMS. All patients had “hotspot” PIK3CA variants on tissue‐based genetic testing. Screening for intracranial vascular anomalies and targeted medical therapy with PI3K/AKT/mTOR pathway inhibitors should be considered in OLM management. Level of Evidence: 3.
- 19 August 2026
- Published by Wiley in The Laryngoscope
Open AccessOrbital Lymphatic Malformations Are Associated With Intracranial Vascular Anomalies
Objectives: Orbital lymphatic malformations (OLMs) are a rare type of lymphatic malformation involving the soft tissues within the bony orbit. OLMs present specific treatment challenges and cause significant morbidity. The contribution of pathologic genetic variants and potential association of intracranial vascular anomalies with OLMs has yet to be described. We hypothesized that (1) OLMs are indicators of underlying cerebrofacial venous metameric syndrome (CVMS) and are associated with intracranial vascular anomalies, and (2) OLMs are caused by PIK3CA variants and are candidates for targeted medical therapy. Methods: Retrospective case review was performed for patients with OLMs treated at a single institution from 2000 to 2025. Diagnosis of CVMS was made via magnetic resonance imaging (MRI) based on established criteria of segmental distribution of ocular, facial, and cerebral vascular malformations. Symptoms, MRI and genetic findings, and management are described. Results: Seven of 412 patients with head and neck lymphatic malformations had OLM. Common symptoms included eye swelling ( n = 7), ptosis ( n = 3), and headache ( n = 5). All patients were diagnosed with CVMS on MRI. All patients underwent surgical resection and were candidates for targeted medical therapy after tissue‐based DNA sequencing revealed “hotspot” PIK3CA variants p.E542K ( n = 4) and p.H1047R ( n = 3). Five patients were started on alpelisib, resulting in symptom improvement at 6 months of treatment. Conclusion: OLMs were associated with intracranial vascular anomalies, meeting radiographic criteria for CVMS. All patients had “hotspot” PIK3CA variants on tissue‐based genetic testing. Screening for intracranial vascular anomalies and targeted medical therapy with PI3K/AKT/mTOR pathway inhibitors should be considered in OLM management. Level of Evidence: 3.
- Open Access
Donor-specific assemblies enhance somatic structural variant detection in complex genomic regions
Structural variants (SVs) contribute substantially to genomic variation and disease, but detecting somatic SVs (sSVs) remains difficult due to reference bias, mosaicism, and enrichment in repetitive regions. Linear reference genomes, like GRCh38 and CHM13, do not fully capture individual genomic structure, which can obscure true somatic variation. Donor-specific assemblies (DSAs) generated from the same genome where sSVs are being assayed provide a personalized alternative, yet their performance for sSV detection has not been systematically assessed. As part of the Somatic Mosaicism across Human Tissues (SMaHT) Network, we benchmark a DSA for sSV discovery in the COLO829 melanoma cell line with a matched normal sample from the same individual. We compare sSV detection across GRCh38, CHM13, and the COLO829BL_DSA using three different sSV callers (Delly, Severus, and Sniffles2) and sequence data from multiple long-read platforms. The COLO829BL_DSA identifies 1.8-fold more manually validated sSVs than linear references, in regions both shared with GRCh38 and CHM13 and unique to the COLO829BL_DSA. Variants detected only with the COLO829BL_DSA are often found in satellite and other repeat-rich regions that are difficult to resolve using standard references. In addition, several COLO829BL_DSA-specific sSVs are located in genes, some of which are cancer associated. Overall, these results underscore the utility of DSAs in improving sSV detection.
Open AccessDonor-specific assemblies enhance somatic structural variant detection in complex genomic regions
Structural variants (SVs) contribute substantially to genomic variation and disease, but detecting somatic SVs (sSVs) remains difficult due to reference bias, mosaicism, and enrichment in repetitive regions. Linear reference genomes, like GRCh38 and CHM13, do not fully capture individual genomic structure, which can obscure true somatic variation. Donor-specific assemblies (DSAs) generated from the same genome where sSVs are being assayed provide a personalized alternative, yet their performance for sSV detection has not been systematically assessed. As part of the Somatic Mosaicism across Human Tissues (SMaHT) Network, we benchmark a DSA for sSV discovery in the COLO829 melanoma cell line with a matched normal sample from the same individual. We compare sSV detection across GRCh38, CHM13, and the COLO829BL_DSA using three different sSV callers (Delly, Severus, and Sniffles2) and sequence data from multiple long-read platforms. The COLO829BL_DSA identifies 1.8-fold more manually validated sSVs than linear references, in regions both shared with GRCh38 and CHM13 and unique to the COLO829BL_DSA. Variants detected only with the COLO829BL_DSA are often found in satellite and other repeat-rich regions that are difficult to resolve using standard references. In addition, several COLO829BL_DSA-specific sSVs are located in genes, some of which are cancer associated. Overall, these results underscore the utility of DSAs in improving sSV detection.
- Open Access
A telomere-to-telomere map of somatic mutation burden and functional impact in cancer
Oncogenesis involves widespread genetic and epigenetic alterations, yet the full spectrum of somatic variation genome-wide remains unresolved. We generated a near-telomere-to-telomere (T2T) diploid assembly of a donor paired with deep short- and long-read sequencing of their melanoma. This revealed that 16% of somatic variants occur in sequences absent from GRCh38, with satellite repeats acting as hotspots for UV-induced damage due to sequence-intrinsic mutability and inefficient repair. Centromere kinetochore domains emerged as focal sites of structural, genetic, and epigenetic variation, leading to remodeling of centromere kinetochore binding domains during tumor evolution. Single-molecule telomere reconstructions uncovered cycles of attrition, deletion, and telomerase-mediated extension that shape cancer telomeres. Finally, diploid chromatin maps exposed that copy number alterations and epimutations, rather than point mutations, predominate in rewiring cancer regulatory programs. These findings define the full landscape of a cancer’s somatic variation and their functional impact, establishing a blueprint for T2T studies of mosaicism.
Open AccessA telomere-to-telomere map of somatic mutation burden and functional impact in cancer
Oncogenesis involves widespread genetic and epigenetic alterations, yet the full spectrum of somatic variation genome-wide remains unresolved. We generated a near-telomere-to-telomere (T2T) diploid assembly of a donor paired with deep short- and long-read sequencing of their melanoma. This revealed that 16% of somatic variants occur in sequences absent from GRCh38, with satellite repeats acting as hotspots for UV-induced damage due to sequence-intrinsic mutability and inefficient repair. Centromere kinetochore domains emerged as focal sites of structural, genetic, and epigenetic variation, leading to remodeling of centromere kinetochore binding domains during tumor evolution. Single-molecule telomere reconstructions uncovered cycles of attrition, deletion, and telomerase-mediated extension that shape cancer telomeres. Finally, diploid chromatin maps exposed that copy number alterations and epimutations, rather than point mutations, predominate in rewiring cancer regulatory programs. These findings define the full landscape of a cancer’s somatic variation and their functional impact, establishing a blueprint for T2T studies of mosaicism.